Dysregulation of angiopoietin 1 and 2 in escherichia coli O157:H7 Infection and the hemolytic-uremic syndrome

Journal of Infectious Diseases

Volumn 208, Issue 6, 2013, Pages 929-933

  Page, Andrea V ^a,b   Tarr, Phillip I ^c   Watkins, Sandra L ^d,e   Rajwans, Nimerta ^b   Petruzziello Pellegrini, Tania N ^f,g   Marsden, Philip A ^f,g,h   Kain, Kevin C ^a,b   Conrad Liles, W ^a,b,e  

^a Division of Infectious Diseases   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f Department of Laboratory Medicine and Pathobiology ^*  (United States)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

angiopoietin 1; angiopoietin 2; E. coli O157:H7; endothelial dysfunction; hemolytic uremic syndrome

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; MESSENGER RNA;

ANGIOPOIETIN 1 GENE; ANGIOPOIETIN 2 GENE; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ESCHERICHIA COLI INFECTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROANGIOPATHY; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR PATHOLOGY; NEWBORN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UPREGULATION;

ANGIOPOIETIN 1; ANGIOPOIETIN 2; E. COLI O157:H7; ENDOTHELIAL DYSFUNCTION; HEMOLYTIC-UREMIC SYNDROME;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; CELLS, CULTURED; CHILD; ENDOTHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PROSPECTIVE STUDIES; SHIGA TOXIN;

EID: 84882683291     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit268     Document Type: Article

References (15)

1. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-86.
2. Lopez EL, Contrini MM, Glatstein E, et al. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factor and serum Shiga-like toxin 2 values. Pediatr Infect Dis J 2012; 31:20-4.
3. Petruzziello-Pellegrini TN, Yuen DA, Page AV, et al. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. J Clin Invest 2012; 122:759-76.
4. van Meurs M, Kumpers P, Ligtenberg JJM, Meertens JHJM, Molema G, Zijlstra JG. Bench-to-bedside review: angiopoietin signaling in critical illness-a future target? Crit Care 2009; 13:207.
5. Kumpers P, Lukasz A, David S, et al. Excess circulating angiopoietin-2 is a strong predictor of mortality in critically ill medical patients. Crit Care 2008; 12:R147.
6. Page AV, Kotb M, McGeer A, Low DE, Kain KC, Liles WC. Systemic dysregulation of angiopoietin-1/2 in streptococcal toxic shock syndrome. Clin Infect Dis 2011; 52:e157-61.
7. Lovegrove FE, Tangpukdee N, Opoka RO, et al. Serum angiopoietin-1 and-2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 2009; 4: e4912.
8. Conroy AL, Glover SJ, Hawkes M, et al. Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study. Crit Care Med 2012; 40:952-9.
9. Chandler WL, Jelacic S, Boster DR, et al. Prothrombotic coagulation abnormalities preceding the haemolytic-uremic syndrome. New Engl J Med 2002; 346:23-32.
10. Thijssen VLJL, Brandwijk RJMGE, Dings RPM, Griffioen AW. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. Exp Cell Res 2004; 299:286-93.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2CT method. Methods 2001; 25:402-8.
12. Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008; 68:6851-8.
13. David S, Park JK, Meurs M, et al. Acute administration of recombinant angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis. Cytokine 2011; 55:251-9.
14. London NR, Zhu W, Bozza FA, et al. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19.
15. Finney CA, Hawkes CA, Kain DC, et al. S1P is associated with protection in human and experimental cerebral malaria. Mol Med 2011; 17:717-25.